Published in Ann Pharmacother on September 05, 2006
Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend (2009) 1.77
Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend (2011) 1.38
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology (Berl) (2013) 1.02
A placebo-controlled trial of modafinil for nicotine dependence. Drug Alcohol Depend (2008) 0.98
Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat (2008) 0.90
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride. Neuropsychiatr Dis Treat (2009) 0.80
Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat (2008) 0.78
Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell (2004) 2.40
A service-learning elective to promote enhanced understanding of civic, cultural, and social issues and health disparities in pharmacy. Am J Pharm Educ (2007) 1.83
Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci (2010) 1.62
Emergency department care for victims of sexual offense. Am J Health Syst Pharm (2007) 1.47
Cardiac rhythm devices in the pediatric population: utilization and complications. Heart Rhythm (2011) 1.44
Adaptation and application of the Agency for Healthcare Research and Quality's asthma admission rate pediatric quality indicator to Ohio Medicaid claims data. Res Social Adm Pharm (2012) 1.38
Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program. Pharmacoepidemiol Drug Saf (2005) 1.28
Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology (Berl) (2008) 1.10
Long-term effects of neonatal methamphetamine exposure in rats on spatial learning in the Barnes maze and on cliff avoidance, corticosterone release, and neurotoxicity in adulthood. Brain Res Dev Brain Res (2003) 1.10
3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatry (2005) 1.06
Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood. Synapse (2005) 1.01
Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. J Neurochem (2006) 1.00
Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med (2003) 0.98
Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment. J Neurochem (2007) 0.97
Beta-blocker underuse in secondary prevention of myocardial infarction. Ann Pharmacother (2003) 0.93
3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. Brain Res (2005) 0.93
Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. J Pharmacol Exp Ther (2004) 0.92
Relationship between asthma drug therapy patterns and healthcare utilization. Ann Pharmacother (2002) 0.91
Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicol Teratol (2010) 0.91
U.S. emergency departments visits resulting from poor medication adherence: 2005-07. J Am Pharm Assoc (2003) (2013) 0.90
MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. J Neuroimmune Pharmacol (2012) 0.88
Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neurosci (2008) 0.88
Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis. Cancer Chemother Pharmacol (2007) 0.86
(+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks. Neuropharmacology (2008) 0.86
Metyrapone attenuates the sequential learning deficits but not monoamine depletions following d,l-fenfluramine administration to adult rats. Synapse (2004) 0.85
Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Brain Res (2005) 0.85
Staged palliation of hypoplastic left heart syndrome: trends in mortality, cost, and length of stay using a national database from 2000 through 2009. Am J Cardiol (2013) 0.85
MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology (2012) 0.85
Evidence for involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex. Neuropharmacology (2012) 0.84
Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting. J Am Pharm Assoc (2003) (2013) 0.84
Activation of 5-HT2 receptors induces glycogenolysis in the rat brain. Eur J Pharmacol (2003) 0.84
3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. Psychopharmacology (Berl) (2005) 0.84
Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat. Brain Res (2004) 0.84
In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opin Drug Discov (2011) 0.84
(+)-Methamphetamine-induced monoamine reductions and impaired egocentric learning in adrenalectomized rats is independent of hyperthermia. Synapse (2010) 0.83
Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain. Brain Res (2009) 0.83
Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain. Eur J Pharmacol (2010) 0.83
3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J Pharmacol Exp Ther (2002) 0.82
Pediatric syncope: National Hospital Ambulatory Medical Care Survey results. J Emerg Med (2012) 0.81
Treatment with a serotonin-depleting regimen of MDMA prevents conditioned place preference to sex in male rats. Behav Neurosci (2007) 0.80
Pharmacist screening for depression among patients with diabetes in an urban primary care setting. J Am Pharm Assoc (2003) (2008) 0.80
Pharmacist-initiated peripheral arterial disease screening program in a community pharmacy setting. J Am Pharm Assoc (2003) (2011) 0.80
Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat. Synapse (2004) 0.80
The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis. Cancer Chemother Pharmacol (2013) 0.80
Differences in the cost of antidepressants across state Medicaid programs. J Ment Health Policy Econ (2008) 0.80
The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats. Neurotoxicol Teratol (2004) 0.79
Antipsychotic medications, glutamate, and cell death: a hidden, but common medication side effect? Med Hypotheses (2012) 0.79
Attention deficit and hyperactivity disorder: controversies of diagnosis and safety of pharmacological and nonpharmacological treatment. Curr Drug Saf (2007) 0.79
Pediatric asthma medication therapy management through community pharmacy and primary care collaboration. J Am Pharm Assoc (2003) (2016) 0.78
Impact of the Food and Drug Administration's antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings. Alzheimers Dement (2012) 0.78
The national burden of E-code-identified adverse drug events among hospitalized children using a national discharge database. Pharmacoepidemiol Drug Saf (2011) 0.77
Implementation of pharmacist training and counseling program on vitamins and minerals. J Am Pharm Assoc (2003) (2007) 0.77
Neonatal methamphetamine-induced corticosterone release in rats is inhibited by adrenal autotransplantation without altering the effect of the drug on hippocampal serotonin. Neurotoxicol Teratol (2010) 0.77
Trends in the outpatient treatment of atrial fibrillation in the USA from 2001 to 2010. Pharmacoepidemiol Drug Saf (2014) 0.77
Characteristics and risk factors associated with high-cost Medicaid recipients. Manag Care Interface (2004) 0.77
The effect of electronic medical record system sophistication on preventive healthcare for women. J Am Med Inform Assoc (2012) 0.77
Firm- and drug-specific patterns of generic drug payments by US medicaid programs: 1991-2008. Appl Health Econ Health Policy (2014) 0.76
Neonatal citalopram treatment inhibits the 5-HT depleting effects of MDMA exposure in rats. ACS Chem Neurosci (2011) 0.76
Inhaled corticosteroid use in asthmatic children receiving Ohio Medicaid: trend analysis, 1997-2001. Ann Allergy Asthma Immunol (2008) 0.76
Development, implementation, and evaluation of a pharmacist-conducted screening program for depression. J Am Pharm Assoc (2003) (2013) 0.76
3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex. Synapse (2005) 0.76
Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain. Drug Deliv (2013) 0.75
Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake. Brain Res Bull (2013) 0.75
Characteristics of Social and Administrative Sciences graduate programs and strategies for student recruitment and future faculty development in the United States. Res Social Adm Pharm (2012) 0.75
National Estimates of and Risk Factors for Inpatient Revision Surgeries for Orofacial Clefts. Cleft Palate Craniofac J (2016) 0.75
Frequencies, costs, and complications of catheter ablation for tachyarrhythmias in children: 2000-2009. Pacing Clin Electrophysiol (2013) 0.75
TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate. J Am Pharm Assoc (2003) (2015) 0.75
Clinical outcomes of switching from insulin glargine to NPH insulin in indigent patients at a charitable pharmacy: The Charitable Insulin NPH: Care for the Indigent (CINCI) study. J Am Pharm Assoc (2003) (2017) 0.75
Medicare Annual Wellness Visits: patient need and pharmacist patient care services intersect. J Am Pharm Assoc (2003) (2014) 0.75
Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991-2009. Clin Ther (2012) 0.75